Health Inc. : Shots - Health News As spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.

Health Inc.

Tuesday

People hoping to get health insurance coverage in 2018 may need to make sure their 2017 premiums are paid. Busakorn Pongparnit/Getty Images hide caption

toggle caption
Busakorn Pongparnit/Getty Images

Monday

Tuesday

Lines like this one at a health insurance enrollment fair at the Ambrose Community Center in Bay Point, Calif., in 2014 may be longer this winter. Justin Sullivan/Getty Images hide caption

toggle caption
Justin Sullivan/Getty Images

Wednesday

Gregory Matthews has glaucoma and uses prescription eyedrops. The dropper's opening creates a bigger drop than he needs, causing him to run out of his medication before the prescription is ready to refill. Matt Roth for ProPublica hide caption

toggle caption
Matt Roth for ProPublica

Drug Companies Make Eyedrops Too Big, And You Pay For The Waste

  • Download
  • <iframe src="https://www.npr.org/player/embed/558358137/558706881" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Sunday

Tape worm pills were once advertised as a way to stay thin. Courtesy of Workman Publishing hide caption

toggle caption
Courtesy of Workman Publishing

'Quackery' Chronicles How Our Love Of Miracle Cures Leads Us Astray

  • Download
  • <iframe src="https://www.npr.org/player/embed/557479531/557863726" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Sunday

Lori Wallace says it's frustrating to constantly hear messages in ads for hospitals that imply her cancer would go away if she were just more positive and tried harder. Sam Harnett/KQED hide caption

toggle caption
Sam Harnett/KQED

The Painful Side Of Positive Health Care Marketing

  • Download
  • <iframe src="https://www.npr.org/player/embed/555370189/564443911" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Drug lobbyists and consumer health advocates fill the halls of the state Capitol in September to see how Assembly members vote on a controversial drug price transparency bill. Tam Ma/Courtesy of Health Access California hide caption

toggle caption
Tam Ma/Courtesy of Health Access California

California Bill Would Compel Drugmakers To Justify Price Hikes

  • Download
  • <iframe src="https://www.npr.org/player/embed/551013546/555710534" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Roughly 1.4 million people in the U.S. live in nursing homes, and two-thirds are covered by Medicaid, the state-federal health care program for people with low incomes or disabilities. Blend Images/Getty Images hide caption

toggle caption
Blend Images/Getty Images

Wednesday

Critics of Anthem's policy say imposing a blanket rule that gives preference to freestanding imaging centers is at odds with promoting quality and will lead to fragmented care for patients. Media for Medical/UIG/Getty Images hide caption

toggle caption
Media for Medical/UIG/Getty Images

Monday

Health insurance company Oscar has started its own ad campaign for the Affordable Care Act. These enrollment dates apply to New York state; the dates to enroll in federally run exchanges are Nov. 1 to Dec. 15. Oscar Health hide caption

toggle caption
Oscar Health

As Federal Government Cuts Obamacare Ads, Private Insurer Steps Up

  • Download
  • <iframe src="https://www.npr.org/player/embed/551776441/551897263" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

FDA Commissioner Scott Gottlieb says the agency will close a loophole that lets drug manufacturers skip pediatric testing in some drugs intended for children. Zach Gibson/Getty Images hide caption

toggle caption
Zach Gibson/Getty Images

Monday

A study of chemotherapy medicines produced by 10 companies found that, on average, each drug produced seven times as much revenue for its manufacturer as it cost in research and development. BrianAJackson/iStockphoto/Getty Images hide caption

toggle caption
BrianAJackson/iStockphoto/Getty Images

R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds

  • Download
  • <iframe src="https://www.npr.org/player/embed/550135932/550218516" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

The Senate health committee meets next month to discuss ways to stabilize the insurance markets. Insurers have until Sept. 27 to commit to selling policies on the ACA marketplaces in 2018. Andrew Harnik/AP hide caption

toggle caption
Andrew Harnik/AP

Tuesday

A California jury awarded a woman $417 million in a case against Johnson & Johnson. The woman claimed that her use of Johnson's Baby Powder led to terminal ovarian cancer. Scientists disagree on how strong a link there is between talc and ovarian cancer. Frederic J. Brown/AFP/Getty Images hide caption

toggle caption
Frederic J. Brown/AFP/Getty Images

Does Baby Powder Cause Cancer? A Jury Says Yes. Scientists Aren't So Sure

  • Download
  • <iframe src="https://www.npr.org/player/embed/545314093/545314096" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript